Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: Implications for other countries
Ulrik Hesse, Brian Godman*, Max Petzold, Andrew Martin, Rickard E. Malmström
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
16Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: Implications for other countries'. Together they form a unique fingerprint.